Epidarex Capital Raises Fund to Make Significant Investments in Early-stage UK Life Sciences

Released: Thursday 29th May 2014

Follow the link to the Epidarex website Epidarex Capital, a leading international venture capital firm, has raised over £47.5 million to lead investments in early-stage life science and health technology companies, including spin-outs from leading research universities.

View all News